drugset / Trial / NCT07342062
Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fed State
RandomizedCrossoverOpen-labelTreatment
Summary
This clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229\_01 at fed state.
Timeline
- Start
- 2026-01-06
- Primary completion
- 2026-02-14
- Completion
- 2026-02-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | DA-1229_01 | Unknown | — | — |
| Comparator | DA-1229_01-R | Unknown | — | — |
Indications
No indication recorded.